Terms: = Breast cancer AND PIM1, PIM, 5292, ENSG00000137193, P11309 AND Clinical Outcome
2 results:
1. Synergistic pim kinase and proteasome inhibition as a therapeutic strategy for MYC-overexpressing triple-negative breast cancer.
Kunder R; Velyunskiy M; Dunne SF; Cho BK; Kanojia D; Begg L; Orriols AM; Fleming-Trujillo E; Vadlamani P; Vialichka A; Bolin R; Perrino JN; Roth D; Clutter MR; Zielinski-Mozny NA; Goo YA; Cristofanilli M; Mendillo ML; Vassilopoulos A; Horiuchi D
Cell Chem Biol; 2022 Mar; 29(3):358-372.e5. PubMed ID: 34525344
[TBL] [Abstract] [Full Text] [Related]
2. Post-irradiation morphoea of the breast: a case report and review of the literature.
Gonzalez-Ericsson PI; Estrada MV; Al-Rohil R; Sanders ME
Histopathology; 2018 Jan; 72(2):342-350. PubMed ID: 29110314
[TBL] [Abstract] [Full Text] [Related]
